CompletedPhase 4NCT01298180
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Maithé TAUBER, MDUniversity Hospital, Toulouse
- Intervention
- Growth hormone (Genotonorm® or Omnitrope®)(drug)
- Enrollment
- 111 enrolled
- Eligibility
- 1-5 years · All sexes
- Timeline
- 2009 – 2013
Study locations (26)
- CHU Amiens Hôpital Nord Service Pédiatrie - Place Victor Pauchet, Amiens, France
- CHU Angers - 4 rue Larrey, Angers, France
- CHG Avignon - 305, rue Raoul Follereau, Avignon, France
- CHU Besançon Hôpital Saint Jacques - 2 Place Saint Jacques, Besançon, France
- CHU Bordeaux Hôpital Pellegrin Service endocrinologie de l'enfant - Place Amélie Raba Léon, Bordeaux, France
- CHU Brest Département de Pédiatrie - 5, ave Foch, Brest, France
- CHU Dijon Service de pédiatrie - 2, Bd Maréchal de lattre de Tassigny, Dijon, France
- CHU Grenoble Service de pédiatrie - BP 217, Grenoble, France
- CHU La Rochelle Service de Pédiatrie - Rue du Dr Schweitzer, La Rochelle, France
- CHRU Lille Hôpital Jeanne de Flandre service de Pédiatrie, Lille, France
- CHU Limoges Hôpital Mère Enfant Service Pédiatrie - 8, ave du Larrey, Limoges, France
- CHU Lorient Hôpital du Scorff Pôle Femme Mère Enfant - Rue Guiguen, Lorient, France
- CHU Lyon Hôpital Debrousse service Pédiatrie, Lyon, France
- AP-HM Hôptal La Timone Service de Pédiatrie Mutidisciplinaire, Marseille, France
- CHU Montpellier Hôpital Arnaud de Villeneuve - 371 ave du doyen Gaston Giraud, Montpellier, France
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01298180 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06420297OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06144645A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSFoundation for Prader-Willi Research